Meet our Team
President & CEO
Jonathan Cohen is the founder, president, and CEO of 20/20 GeneSystems. Under Mr. Cohen’s leadership, 20/20 has brought in approximately $7.5 million in grant funding and launched two successful products, a bio-detection kit for suspicious powders used by hundreds of emergency responder organizations worldwide and a blood test for the early detection of lung cancer. He is the co-inventor of an AI approach for improving tumor biomarker accuracy that is covered in a pending PCT International Patent Application.
Michael Leibowitz, PHD
CHIEF SCIENTIFIC OFFICER
Jiming Zhou, Ph.D.
CHIEF OPERATING OFFICER
ZHOU GRADUATED FROM SICHUAN UNIVERSITY (CHINA) AND SERVED AS AN ASSOCIATE PROFESSOR BEFORE MOVING TO THE US, CONDUCTING 7 YEARS ACADEMIC RESEARCH AT UNIVERSITY OF IOWA. DR. ZHOU PUBLISHED 30+ PEER-REVIEWED RESARCH PAPER, AWARDED MULTIPLE GRANTS AND PATENTS.
IN 2005, DR. ZHOU THEN JOINED INDUSTRIAL R&D, LED A JOINT PHARMACEUTICAL PROJECT TOTAL MILESTONES OF $330 MILLION. FROM 2009, DR. ZHOU MANAGED MULTIPLE CLINICAL LABS AND CO-FUNDED 2 COMPANIES, WORKED WITH MANY LARGE US AND CHINESE PUBLIC AND PRIVATE HEALTHCARE INSTITUTES IN MULTIPLE PROJECTS.